Concepedia
Statistics
Publications
6
Citations
391
H-Index
Active since
1990
Affiliations
Vantia (United Kingdom)(Current)
W.E. Upjohn Institute for Employment Research
D. Michael Evans is an author at Vantia (United Kingdom) specializing in medicine, pharmacology, and life sciences.
Publications per year
1990–2016
Chronic Inhibition of Circulating Dipeptidyl Peptidase IV by FE 999011 Delays the Occurrence of Diabetes in Male Zucker Diabetic Fatty Rats
Béatrice Sudre, Pierre Broqua, Richard White et al. · Diabetes · 2002 · 168 citations · Full text
Medicine, Endocrinology, Pharmacology +16
A Synthetic Tissue Kallikrein Inhibitor Suppresses Cancer Cell Invasiveness
William C. De Wolf, D. Michael Evans, Lee Chao et al. · American Journal Of Pathology · 2001 · 63 citations · Full text
Medicine, Cancer Biology, Oncology +9
Metal affinity chromatography of recombinant HIV‐1 reverse transcriptase containing a human renin cleavable metal binding domain
Sharma Sk, D. Michael Evans, AF Vosters et al. · Biotechnology and Applied Biochemistry · 1991 · 53 citations
Life Sciences, Biochemistry, Molecular Biology +15
Activation profiles of human kallikrein‐related peptidases by proteases of the thrombostasis axis
Hyesook Yoon, Sachiko I. Blaber, D. Michael Evans et al. · Protein Science · 2008 · 49 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +12
Plasma Kallikrein Mediates Vascular Endothelial Growth Factor–Induced Retinal Dysfunction and Thickening
Allen C. Clermont, Nivetha Murugesan, Qunfang Zhou et al. · Investigative Ophthalmology & Visual Science · 2016 · 34 citations · Full text
Medicine, Ophthalmology, Vision Science +17
1–5 of 6